Topical Tacrolimus in Thygeson Superficial Punctate Keratitis

Conclusions: Topical tacrolimus 0.02% is safe and effective in reducing ocular surface inflammation in patients with Thygeson superficial punctate keratitis who are not responsive to conventional therapy. Tacrolimus is helpful as a steroid-sparing agent to avoid vision-threatening complications.
Source: Cornea - Category: Opthalmology Tags: Clinical Science Source Type: research